NRC Health
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M | $37.3M | $32.4M | $30.0M |
| Depreciation & Amortization | $7.6M | $6.0M | $5.9M | — | — | — | $5.5M | $5.5M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K |
| Stock-Based Compensation | $3.3M | $284.0K | $935.0K | $1.2M | $623.0K | $680.0K | $1.2M | $1.5M |
| Net Cash from Operating Activities | $26.5M | $34.6M | $38.1M | $36.3M | $46.3M | $40.6M | $40.9M | $39.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $10.7M | $15.4M | $15.8M | $9.8M | $5.5M | $4.0M | $4.7M | $6.0M |
| Business Acquisitions | $0 | $4.8M | $0 | $0 | $3.0M | — | — | — |
| Net Cash from Investing Activities | $-10.7M | $-20.3M | $-15.8M | $-9.8M | $-8.5M | $-3.7M | $-4.7M | $-6.0M |
| Financing Activities | ||||||||
| Dividends Paid | $11.0M | $11.5M | $36.4M | $21.0M | $9.2M | $10.5M | $31.3M | $16.9M |
| Stock Repurchases | $20.2M | $30.9M | $19.1M | $27.6M | $4.1M | — | — | — |
| Net Cash from Financing Activities | $-15.8M | $-16.8M | $-40.7M | $-55.6M | $-18.2M | $-15.5M | $-36.3M | $-54.5M |
| Net Change in Cash | $-94.0K | $-2.4M | $-18.4M | $-29.3M | $19.7M | $21.2M | $526.0K | $-21.7M |
| Free Cash Flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M | $36.7M | $36.3M | $33.9M |